Prognostic and Predictive Value of Tumor Molecular Alterations in Patients With Prostate Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT04983628

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:39:17.964036+00:00

Published At

2023-03-01T00:00:00+00:00

Record Updated At

2023-03-01

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Prostate Cancer Metastatic", "Prostate Cancer Recurrent", "Germline BRCA1 Gene Mutation", "Germline BRCA2 Gene Mutation", "Mutation"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2023-03-01"

protocolSection.identificationModule.nctId

"NCT04983628"

protocolSection.identificationModule.officialTitle

"Prognostic and Predictive Value of Tumor Molecular Alterations in Patients With Prostate Cancer"

protocolSection.statusModule.overallStatus

"UNKNOWN"

protocolSection.designModule.phases

[]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Prostate Cancer Metastatic (protocolSection.conditionsModule.conditions)
• Prostate Cancer Recurrent (protocolSection.conditionsModule.conditions)
• Germline BRCA1 Gene Mutation (protocolSection.conditionsModule.conditions)
• Germline BRCA2 Gene Mutation (protocolSection.conditionsModule.conditions)
• Mutation (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.